CENTOGENE expands COVID-19 testing capacity at Frankfurt Airport
CENTOGENE opens an expanded sampling area directly adjacent to the existing Walk-In COVID 19 test center, significantly increasing the capacity for throat swab COVID 19 testing
Innovative digital solutions are an important tool in the fight against the new coronavirus and offer a user-friendly testing experience
CAMBRIDGE, Mass, USA and ROSTOCK & BERLIN, Germany, September 10, 2020: CENTOGENE N.V. (Nasdaq: CNTG), a commercial enterprise specializing in the diagnosis of rare diseases using clinical and genetic data to answer medical questions from patients, physicians and pharmaceutical companies, today announced the expansion of its SARS CoV-2 testing capacity at Frankfurt Airport to continue to support safe travel for passengers as international borders reopen and a new normality returns.
Translated with www.DeepL.com/Translator (free version)